News | November 06, 2025
Marksans Pharma’s UK Arm Relonchem secures MHRA nod for Exemestane 25mg Tablets
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
Cupid has been allocated approximately 23.4 million units of female condoms per year
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
Subscribe To Our Newsletter & Stay Updated
